A Systematic Review and Network Meta-Analysis on the Efficacy of Medications in the Treatment of Chronic Idiopathic Constipation in Japan

Background. In the 2010s, medications with new mechanisms were introduced in Japan for the treatment of chronic idiopathic constipation (CIC). A few systematic reviews have compared medications’ relative efficacy, but the reviews included studies on patients from various races, even though the mecha...

Full description

Saved in:
Bibliographic Details
Main Authors: Atsushi Nakajima, Ayako Shoji, Kinya Kokubo, Ataru Igarashi
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2021/5534687
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563077169545216
author Atsushi Nakajima
Ayako Shoji
Kinya Kokubo
Ataru Igarashi
author_facet Atsushi Nakajima
Ayako Shoji
Kinya Kokubo
Ataru Igarashi
author_sort Atsushi Nakajima
collection DOAJ
description Background. In the 2010s, medications with new mechanisms were introduced in Japan for the treatment of chronic idiopathic constipation (CIC). A few systematic reviews have compared medications’ relative efficacy, but the reviews included studies on patients from various races, even though the mechanism of CIC is considered to differ between races. The aim of this study was to use a systematic review and network meta-analysis to compare the relative efficacy of these medications in Japanese patients. Methods. We conducted a meta-analysis and report it here according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). We identified studies by searching MEDLINE (via the PubMed interface) and the Cochrane Library and ICHUSHI databases and included randomized clinical trials that compared medications for CIC with placebo in Japanese adults. Two reviewers independently screened and assessed articles, abstracted data, and assessed the risk of bias. We pooled data by random-effects meta-analyses and also performed a Bayesian network meta-analysis to indirectly compare data. Results. The present systematic review and meta-analyses included 1460 patients in 6 randomized clinical trials: 2 on linaclotide, 3 on elobixibat, 2 on lubiprostone, and 1 on lactulose. The results of direct comparisons showed that linaclotide, elobixibat, and lubiprostone were superior to placebo in the change of spontaneous bowel movements (SBMs) within 1 week: linaclotide, 1.95 (95% CI, 1.51-2.39); elobixibat, 5.69 (95% CI, 3.31-8.07); and lubiprostone, 2.41 (95% CI, 0.82-4.01). The Bayesian network meta-analysis showed consistent results. Elobixibat 10 mg was ranked first for the increase in SBMs and complete SBMs within 1 week and the time to first SBM. Lubiprostone 48 μg was ranked first for the proportion of patients with SBM within 24 hours. Conclusion. Our direct and indirect meta-analyses revealed that the new CIC medications available in Japan have equal efficacy but that elobixibat and lubiprostone are highly likely to be more efficacious.
format Article
id doaj-art-4a4d6432236e45a6aed6c926659a1313
institution Kabale University
issn 1687-630X
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-4a4d6432236e45a6aed6c926659a13132025-02-03T01:21:04ZengWileyGastroenterology Research and Practice1687-630X2021-01-01202110.1155/2021/5534687A Systematic Review and Network Meta-Analysis on the Efficacy of Medications in the Treatment of Chronic Idiopathic Constipation in JapanAtsushi Nakajima0Ayako Shoji1Kinya Kokubo2Ataru Igarashi3Gastroenterology and HepatologyMedileadMedileadDepartment of Health Economics and Outcomes ResearchBackground. In the 2010s, medications with new mechanisms were introduced in Japan for the treatment of chronic idiopathic constipation (CIC). A few systematic reviews have compared medications’ relative efficacy, but the reviews included studies on patients from various races, even though the mechanism of CIC is considered to differ between races. The aim of this study was to use a systematic review and network meta-analysis to compare the relative efficacy of these medications in Japanese patients. Methods. We conducted a meta-analysis and report it here according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). We identified studies by searching MEDLINE (via the PubMed interface) and the Cochrane Library and ICHUSHI databases and included randomized clinical trials that compared medications for CIC with placebo in Japanese adults. Two reviewers independently screened and assessed articles, abstracted data, and assessed the risk of bias. We pooled data by random-effects meta-analyses and also performed a Bayesian network meta-analysis to indirectly compare data. Results. The present systematic review and meta-analyses included 1460 patients in 6 randomized clinical trials: 2 on linaclotide, 3 on elobixibat, 2 on lubiprostone, and 1 on lactulose. The results of direct comparisons showed that linaclotide, elobixibat, and lubiprostone were superior to placebo in the change of spontaneous bowel movements (SBMs) within 1 week: linaclotide, 1.95 (95% CI, 1.51-2.39); elobixibat, 5.69 (95% CI, 3.31-8.07); and lubiprostone, 2.41 (95% CI, 0.82-4.01). The Bayesian network meta-analysis showed consistent results. Elobixibat 10 mg was ranked first for the increase in SBMs and complete SBMs within 1 week and the time to first SBM. Lubiprostone 48 μg was ranked first for the proportion of patients with SBM within 24 hours. Conclusion. Our direct and indirect meta-analyses revealed that the new CIC medications available in Japan have equal efficacy but that elobixibat and lubiprostone are highly likely to be more efficacious.http://dx.doi.org/10.1155/2021/5534687
spellingShingle Atsushi Nakajima
Ayako Shoji
Kinya Kokubo
Ataru Igarashi
A Systematic Review and Network Meta-Analysis on the Efficacy of Medications in the Treatment of Chronic Idiopathic Constipation in Japan
Gastroenterology Research and Practice
title A Systematic Review and Network Meta-Analysis on the Efficacy of Medications in the Treatment of Chronic Idiopathic Constipation in Japan
title_full A Systematic Review and Network Meta-Analysis on the Efficacy of Medications in the Treatment of Chronic Idiopathic Constipation in Japan
title_fullStr A Systematic Review and Network Meta-Analysis on the Efficacy of Medications in the Treatment of Chronic Idiopathic Constipation in Japan
title_full_unstemmed A Systematic Review and Network Meta-Analysis on the Efficacy of Medications in the Treatment of Chronic Idiopathic Constipation in Japan
title_short A Systematic Review and Network Meta-Analysis on the Efficacy of Medications in the Treatment of Chronic Idiopathic Constipation in Japan
title_sort systematic review and network meta analysis on the efficacy of medications in the treatment of chronic idiopathic constipation in japan
url http://dx.doi.org/10.1155/2021/5534687
work_keys_str_mv AT atsushinakajima asystematicreviewandnetworkmetaanalysisontheefficacyofmedicationsinthetreatmentofchronicidiopathicconstipationinjapan
AT ayakoshoji asystematicreviewandnetworkmetaanalysisontheefficacyofmedicationsinthetreatmentofchronicidiopathicconstipationinjapan
AT kinyakokubo asystematicreviewandnetworkmetaanalysisontheefficacyofmedicationsinthetreatmentofchronicidiopathicconstipationinjapan
AT ataruigarashi asystematicreviewandnetworkmetaanalysisontheefficacyofmedicationsinthetreatmentofchronicidiopathicconstipationinjapan
AT atsushinakajima systematicreviewandnetworkmetaanalysisontheefficacyofmedicationsinthetreatmentofchronicidiopathicconstipationinjapan
AT ayakoshoji systematicreviewandnetworkmetaanalysisontheefficacyofmedicationsinthetreatmentofchronicidiopathicconstipationinjapan
AT kinyakokubo systematicreviewandnetworkmetaanalysisontheefficacyofmedicationsinthetreatmentofchronicidiopathicconstipationinjapan
AT ataruigarashi systematicreviewandnetworkmetaanalysisontheefficacyofmedicationsinthetreatmentofchronicidiopathicconstipationinjapan